Literature DB >> 8743282

The primary role of steroids on the osteoporosis in juvenile rheumatoid patients evaluated by dual energy X-ray absorptiometry.

F Falcini1, S Trapani, R Civinini, A Capone, M Ermini, G Bartolozzi.   

Abstract

Osteoporosis, a common clinical feature in children affected with Juvenile Rheumatoid Arthritis (JRA), is generally divided into two forms, a localized juxta-articular osteoporosis of the single joints and a generalized reduction of bone mass due to the disease itself, joint involvement and steroid treatment. Recently Dual Energy X-ray Absorptiometry (DEXA) has been suggested for Bone Mineral Density (BMD) measurement. In the present study DEXA has been used to investigate the lumbar spine BMD in JRA patients as compared to healthy children. Our results showed that BMD is reduced in JRA patients (BMD 0.685 g/cm2) when compared to healthy children (BMD 0.722 g/cm2), and it is significantly lower in the group of patients treated with steroids (BMD 0.623 g/cm2) when compared to those treated with nonsteroidal antiinflammatory drugs (BMD 0.710 g/cm2). The analysis of all risk factors of bone loss indicated that steroids represent the only parameter of significant negative correlation with BMD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743282     DOI: 10.1007/bf03349860

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.

Authors:  J Loftus; R Allen; R Hesp; J David; D M Reid; D J Wright; J R Green; J Reeve; B M Ansell; P M Woo
Journal:  Pediatrics       Date:  1991-09       Impact factor: 7.124

2.  Comparative assessment of dual-photon absorptiometry and dual-energy radiography.

Authors:  C C Glüer; P Steiger; R Selvidge; K Elliesen-Kliefoth; C Hayashi; H K Genant
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

Review 3.  Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.

Authors:  J Dequeker; R Westhovens
Journal:  J Rheumatol       Date:  1995-06       Impact factor: 4.666

4.  Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry.

Authors:  H Kröger; A Kotaniemi; P Vainio; E Alhava
Journal:  Bone Miner       Date:  1992-04

5.  Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents.

Authors:  S Howe; J Levinson; E Shear; S Hartner; G McGirr; M Schulte; D Lovell
Journal:  Arthritis Rheum       Date:  1991-07

6.  Osteoporosis in rheumatoid arthritis.

Authors:  L V Avioli
Journal:  Arthritis Rheum       Date:  1987-07

7.  Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine.

Authors:  H W Wahner; W L Dunn; M L Brown; R L Morin; B L Riggs
Journal:  Mayo Clin Proc       Date:  1988-11       Impact factor: 7.616

8.  Repair of osteopenia in children with juvenile rheumatoid arthritis.

Authors:  A M Reed; M Haugen; L M Pachman; C B Langman
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

9.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

Authors:  C Glastre; P Braillon; L David; P Cochat; P J Meunier; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

10.  Deflazacort in juvenile chronic arthritis.

Authors:  J K Loftus; J Reeve; R Hesp; J David; B M Ansell; P M Woo
Journal:  J Rheumatol Suppl       Date:  1993-04
View more
  12 in total

Review 1.  A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.

Authors:  Karen E Hansen; Brian Kleker; Nasia Safdar; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2014-02-11       Impact factor: 5.532

Review 2.  Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Authors:  Johannes Roth; Susanne Bechtold; Gudrun Borte; Frank Dressler; Hermann J Girschick; Michael Borte
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

3.  Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study.

Authors:  Emily von Scheven; Catherine M Gordon; David Wypij; Marcia Wertz; Kerry T Gallagher; Laura Bachrach
Journal:  J Pediatr Endocrinol Metab       Date:  2006-06       Impact factor: 1.634

4.  Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.

Authors:  A M Huber; I Gaboury; D A Cabral; B Lang; A Ni; D Stephure; S Taback; P Dent; J Ellsworth; C LeBlanc; C Saint-Cyr; R Scuccimarri; J Hay; B Lentle; M Matzinger; N Shenouda; D Moher; F Rauch; K Siminoski; L M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

Review 5.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

6.  Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.

Authors:  Yuzaburo Inoue; Naoki Shimojo; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Masanori Minagawa; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2008-03-11       Impact factor: 2.980

Review 7.  Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

Authors:  Emily von Scheven; Kathleen Jo Corbin; Stefano Stagi; Stagi Stefano; Rolando Cimaz
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

8.  Bone turnover is reduced in children with juvenile rheumatoid arthritis.

Authors:  F Falcini; M Ermini; F Bagnoli
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

9.  [Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology].

Authors:  J Roth; S Bechtold; G Borte; F Dressler; H Girschick; M Borte
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372

10.  Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.

Authors:  Stefano Stagi; Loredana Cavalli; Carla Signorini; Federico Bertini; Marco Matucci Cerinic; Maria Luisa Brandi; Fernanda Falcini
Journal:  Arthritis Res Ther       Date:  2014-03-31       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.